Pharmacologic management and treatment of gastroesophageal reflux disease.
Gastroesophageal reflux disease (GERD) is one of the most common diagnoses in daily practice. Diagnosis can be made on symptom evaluation, on pH-monitoring or on endoscopic findings. In contrast to commonly held opinion there is no strong evidence that lifestyle factors are a dominant factor in the pathophysiology of GERD. The various agents currently used for treatment of GERD include mucoprotective substances, antacids, H(2)-blockers and proton pump inhibitors. This article gives an overview of the pharmacological management of GERD and focuses on the differential therapy of endoscopy-negative GERD, GERD with esophagitis and maintenance therapy.
Storr
M
M
Department of Internal Medicine II - Standort Grosshadern, Ludwig-Maximilians University, Munich, Germany. martin.storr@med.uni-muenchen.de
Meining
A
A
D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D017442:Histamine Agonists / Q000627:therapeutic use; D006699:Home Care Services; D006801:Humans; D054328:Proton Pump Inhibitors
D005765:Gastrointestinal Agents; D017442:Histamine Agonists; D054328:Proton Pump Inhibitors